SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS

摘要

The present invention relates to novel compounds of general formula (I), wherein R1-R4 are defined in the claims, their pharmaceutically acceptable salts and to a process for preparing the same. The present invention also relates to the method of treating inflammatory diseases mediated via activation of p38 MAP kinase, i.e. rheumatoid arthritis, using the compound of formula (I). The present invention relates as well to the use of the compound of formula (I) as a medicament suitable for the treatment of mentioned diseases.